Back to search

Article

The mechanism of Icariside II on NSCLC/COVID-19 based on network pharmacology and molecular docking

2022-07-01

Abstract excerpt

Patients with non-small cell lung cancer (NSCLC) are susceptible to coronavirus disease-2019 (COVID-19), but related treatments are limited. Icariside II (IS), a metabolite of plant Epimedin, showed anti-inflammation and immunoregulation effects in various diseases. This study aimed to evaluate the effect and mechanisms of IS on NSCLC/COVID-19. Targets of NSCLC/COVID-19 were defined as the common targets of NSCLC...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5d582c24-354c-5fe4-b356-b00103a415c1
DOI
10.21203/rs.3.rs-1813850/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The mechanism of Icariside II on NSCLC/COVID-19 based on network pharmacology and molecular dockingDOI 10.21203/rs.3.rs-1813850/v1
Network Pharmacology and Comparative Transcriptome Reveals Biotargets and Mechanisms of Curcumol Treating Lung Adenocarcinoma Patients With COVID-19Semantic proximity
Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of Naringenin against COVID-19/LUSCSemantic proximity
Identification of common key genes and pathways between Covid-19 and lung cancer by using protein-protein interaction network analysisSemantic proximity
Network of “drug-target-SARS-CoV-2 Related Genes” Through Integrated Analysis of Pharmacology and Geo DatabaseSemantic proximity
Uncovering the underlying mechanisms of Compound Yuxingcao Mixture in the treatment of COVID-19 based on network pharmacologySemantic proximity
Exploration of Fuzheng Yugan Mixture on COVID-19 based on network pharmacology and molecular dockingSemantic proximity
Investigating the mechanism of ShuFeng JieDu capsule for the treatment of novel Coronavirus pneumonia (COVID-19) based on network pharmacologySemantic proximity
Molecular Basis for Treating COVID-19 with Official Chinese Herbal Formula LCTESemantic proximity
Antiviral Activity and Underlying Mechanism of Moslae Herba Aqueous Extract for Treating SARS-CoV-2Semantic proximity
Exploration of Potential Targets and Mechanisms of Fisetin in the Treatment of Non-Small-Cell Lung Carcinoma via Network Pharmacology and In Vitro ValidationSemantic proximity
Identifying potential novel insights for COVID-19 pathogenesis and therapeutics using an integrated bioinformatics analysis of host transcriptomeSemantic proximity
Network module analysis and molecular docking-based study on the mechanism of astragali radix against non-small cell lung cancerSemantic proximity
Select a neighboring publication to make it the new centre.